CLASS II ONGOING Device recall · Reported 5 Apr 2023 · FDA Enforcement Report

Acl Elite Pro-Analyzer designed specifically recalled

Instrumentation Laboratory is recalling Acl Elite Pro-Analyzer designed specifically for clinical use in the hemostasis, distributed nationwide in the US. The recall was initiated on 3 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 08426950451570 Serial Number 23015246 and Prior
Quantity recalled129 units US; 2686 units OUS

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1305-2023
FDA event ID
91748
Recalling firm
Instrumentation Laboratory, Bedford, MA
Classification
Class II
Status
Ongoing
Recall initiated
3 Feb 2023
FDA classified
30 Mar 2023
Reported
5 Apr 2023
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Other Reasons

Timeline

3 Feb 2023Recall initiated by company
30 Mar 2023Classified by FDA+55 days
5 Apr 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Removes the test definition for HemosIL Liquid Anti-Xa (PN 0020302600 and 0020302601) from the ACL Elite/Elite Pro instruments

Product as listed by the FDA

ACL ELITE PRO-Analyzer designed specifically for clinical use in the hemostasis laboratory, for coagulation and/or fibrinolysis testing. Part Number: 0001000311

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Canada, Albania, Algeria, Australia, Austria, Azerbaijan, Belarus, Belgium, Brazil, Bulgaria, Cape Verde, China, Colombia, Czech Republic, Egypt, Falkland Islands, Finland, France, Georgia, Germany, Ghana, Greece, Hong Kong, Hungary, India, Indonesia, Iran, Ireland, Italy, Japan, Jordan, Kazakhstan, Kenya, Kossovo, Latvia, Lebanon, Lithuania, Malawi, Malaysia, Mexico, Philippines, Poland, Romania, Russian Fed., Saudi Arabia, Serbia, South Africa, South Korea, Spain, Sri Lanka, Switzerland, Taiwan, Thailand, Ukraine, United Kingdom, Uruguay, Utd.Arab Emir., Vietnam, Zimbabwe.

Nationwide Georgia

Questions about this recall

Why was it recalled?

Removes the test definition for HemosIL Liquid Anti-Xa (PN 0020302600 and 0020302601) from the ACL Elite/Elite Pro instruments

Which lots are affected?

UDI: 08426950451570 Serial Number 23015246 and Prior

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Canada, Albania, Algeria, Australia, Austria, Azerbaijan, Belarus, Belgium, Brazil, Bulgaria, Cape Verde, China, Colombia, Czech Republic, Egypt, Falkland Islands, Finland, France, Georgia, Germany, Ghana, Greece, Hong Kong, Hungary, India, Indonesia, Iran, Ireland, Italy, Japan, Jordan, Kazakhstan, Kenya, Kossovo, Latvia, Lebanon, Lithuania, Malawi, Malaysia, Mexico, Philippines, Poland, Romania, Russian Fed., Saudi Arabia, Serbia, South Africa, South Korea, Spain, Sri Lanka, Switzerland, Taiwan, Thailand, Ukraine, United Kingdom, Uruguay, Utd.Arab Emir., Vietnam, Zimbabwe.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 91748

This product is part of a recall event; the main page for the event is ACL Elite Refurbished-Analyzer designed specifically recalled.

More recalls from Instrumentation Laboratory

All 77

Other Test Kits & Diagnostics recalls

All 2,656